Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 981 entries
View as:

Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study

Phase: N/A Priority: Normal
NCT ID: NCT04296786 Org: User:
Start: 11/01/19 End: 12/31/24 Due: 12/31/25

Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention

Phase: N/A Priority: Normal
NCT ID: NCT02748330 Org: User:
Start: 06/30/16 End: 12/31/18 Due: 12/31/19

Establishment of Emergency Surgery Triage and Checklist Management System

Phase: N/A Priority: Normal
NCT ID: NCT06501157 Org: User:
Start: 06/01/24 End: 12/01/25 Due: 12/01/26

18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor

Phase: N/A Priority: Normal
NCT ID: NCT05069220 Org: User:
Start: 09/01/21 End: 12/31/26 Due: 12/31/27

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06353061 Org: User:
Start: 04/15/24 End: 02/01/26 Due: 02/01/27

177Lu-AB-3PRGD2 in Patients With Integrin αVβ3 Positive Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05013086 Org: User:
Start: 10/01/21 End: 12/01/24 Due: 12/01/25

68Ga-NYM096/177Lu-NYM096 in Metastatic ccRCC

Phase: N/A Priority: Normal
NCT ID: NCT06649682 Org: User:
Start: 11/21/24 End: 10/31/27 Due: 10/31/28

Comparing the Impact of Multimodal Prehabilitation to Aerobic Training on Patients Undergoing Thoracoscopic Lobectomy

Phase: N/A Priority: Normal
NCT ID: NCT04049942 Org: User:
Start: 09/01/19 End: 03/30/24 Due: 03/30/25

Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT01755923 Org: User:
Start: 12/31/12 End: 12/31/14 Due: 12/31/15

Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT02204878 Org: User:
Start: 07/31/14 End: - Due: -

Clinical Study of Vascular Imaging Evaluation of Computed Tomography Photoacoustic Breast Imaging System

Phase: N/A Priority: Normal
NCT ID: NCT04825444 Org: User:
Start: 03/31/21 End: 12/31/21 Due: 12/31/22

Web-based Home Multimodal Prehabilitation for Patients Undergoing Major Surgeries

Phase: N/A Priority: Normal
NCT ID: NCT05324345 Org: User:
Start: 09/01/23 End: 03/01/24 Due: 03/01/25

The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics

Phase: N/A Priority: Normal
NCT ID: NCT06362343 Org: User:
Start: 01/01/24 End: 01/30/27 Due: 01/30/28

A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female

Phase: N/A Priority: Normal
NCT ID: NCT03516266 Org: User:
Start: 05/10/18 End: 12/31/20 Due: 12/31/21

Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement

Phase: N/A Priority: Normal
NCT ID: NCT05789017 Org: User:
Start: 07/01/22 End: 12/31/24 Due: 12/31/25

A Phase II Trial to Explore Niraparib and Anlotinib Maintenance Retreatment in Platinum-Sensitive Recurrent Ovarian Cancer Patients Previously Treated With PARPi

Phase: N/A Priority: Normal
NCT ID: NCT05385068 Org: User:
Start: 06/30/22 End: 09/30/24 Due: 09/30/25

Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03850769 Org: User:
Start: 05/01/19 End: 04/30/22 Due: 04/30/23

Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP

Phase: N/A Priority: Normal
NCT ID: NCT05135442 Org: User:
Start: 12/01/21 End: 11/30/25 Due: 11/30/26

Hypofractionated Online Adaptive Radiotherapy of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06568705 Org: User:
Start: 09/01/24 End: 12/31/26 Due: 12/31/27

Effect of Balanced Saline Solution and Albumin on Volume Expansion in Shock Patients

Phase: N/A Priority: Normal
NCT ID: NCT05463471 Org: User:
Start: 08/01/22 End: 12/12/27 Due: 12/12/28

Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes

Phase: N/A Priority: Normal
NCT ID: NCT02754180 Org: User:
Start: 03/31/16 End: 03/31/21 Due: 03/31/22

Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe Illness

Phase: N/A Priority: Normal
NCT ID: NCT05689034 Org: User:
Start: 04/19/23 End: 12/31/25 Due: 12/31/26

Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China

Phase: N/A Priority: Normal
NCT ID: NCT02647554 Org: User:
Start: 12/31/16 End: 08/01/21 Due: 08/01/22

Safety and Efficacy Study of PUMCH-E101 Injection in Subjects with RDH12 Retinopathy

Phase: N/A Priority: Normal
NCT ID: NCT06749639 Org: User:
Start: 09/20/24 End: 01/04/30 Due: 01/04/31

Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study

Phase: N/A Priority: Normal
NCT ID: NCT06037239 Org: User:
Start: 07/01/23 End: 07/31/25 Due: 07/31/26